Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Canopy Growth

SNDL Inc.

Cannabis companies Tilray Brands Inc. (NASDAQ: TLRY), Sundial Growers Inc. (NASDAQ: SNDL) and Canopy Growth Corp. (NASDAQ: CGC) are seeing high interest from retail investors as of late Thursday. What Happened: Tilray and Sundial are the second and eleventh most discussed stocks on Reddit's.

Why Tilray, Sundial And Canopy Growth Are Seeing High Interest From Retail Investors

Tilray Inc (NASDAQ: TLRY) stock opened more than 15% up on Friday after Marijuana Moment said the U.S. lawmakers are scheduled for a hearing on federal legalization of marijuana next week. Could cannabis be federally legalized in the U.S.?

Tilray stock opened 15% up on Friday: what happened?

The cannabis sector is in the spotlight, after news that the U.S. House of Representatives is scheduled to consider a cannabis decriminalization bill next week.

Sector Surge Sends 2 Cannabis Stocks Higher Out of the Gate

HEXO Corp

Aurora Cannabis

Clever Leaves Holdings Inc

High Tide

OrganiGram Holdings Inc.

Cannabis stocks are trending higher across the board on reports that Congress again plans to take up legalization at the federal level. The post Cannabis Stocks: Why Are TLRY, SNDL, CGC, ACB, HEXO, CLVR, OGI, HITI Stocks Up Today?

Cannabis Stocks: Why Are TLRY, SNDL, CGC, ACB, HEXO, CLVR, OGI, HITI Stocks Up Today?

Cannabis stocks were surging Friday after the House of Representatives said next week it would consider a bill to decriminalize marijuana.

Tilray, Sundial, and Other Cannabis Stocks Buzz. The House Will Consider Decriminalization.

Cronos Group

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ: CRON), Sundial Growers Inc (NASDAQ: SNDL) and Tilray Inc (NASDAQ: TLRY), are all trading higher during Friday's pre-market session on continued.

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Rising

Lawmakers taking fresh steps toward federal legalization of cannabis sparked a rally in cannabis stocks on Friday.

Cannabis Watch: Cannabis stocks rally on flurry of federal moves toward legalization

ExxonMobil is redirecting billions in capital to a low-carbon lifestyle, both to reduce emissions and increase shareholder returns.

Tilray: Keeping Competition Alive

AFC Gamma

Amplify Seymour Cannabis ETF

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

WM Technology

CNBC's Tim Seymour returns to talk cannabis investing within current market conditions.

Cannabis Industry Growth Will Return In Second Half Of 2022 (Podcast Transcript)

Amplify Alternative Harvest ETF

Find out which sector got the best news it's gotten in a while.

Markets Jumped Thursday, and These Hard-Hit Stocks Might Finally Have Their Day in the Sun

For only the second time ever, cannabis legalization will get a floor vote in Congress.

Why Marijuana Stocks Lit Up on Thursday

Renew ‘Moonlight' by Solei, CBN Vape Pen, Now Available Across Canada Renew ‘Moonlight' by Solei, CBN Vape Pen, Now Available Across Canada

Solei Brand Launches New Wellness Product For Nighttime Use

Canopy Growth Corporation (NASDAQ: CGC) and Tilray, Inc (NASDAQ: TLRY) gapped up slightly higher on Wednesday after running up to 7.43% and 12.87%, respectively, in the after-hours trading session on Tuesday. The beaten down cannabis sector has seen renewed interest recently, with several high-.

Why Tilray, Canopy Growth Look Set For New Highs Despite Failing To Hold After-Hours Surge

AMC Entertainment

Advanced Micro Devices

GameStop

NVIDIA

Ready Capital Corp

SPDR S&P 500 ETF Trust

Tesla

WallStreetBets continues to be a den of meme traders and we're checking in on the top trending stocks in the Reddit community for Wednesday. The post 8 Top Stocks Trending on Reddit WallStreetBets Today appeared first on InvestorPlace.

8 Top Stocks Trending on Reddit WallStreetBets Today

Marijuana stocks are making major moves on Wednesday as investors react to news of a couple of mergers taking place in the sector. The post Marijuana Stocks: The M&A News Lighting Up TLRY, CGC, ACB and SNDL Today appeared first on InvestorPlace.

Marijuana Stocks: The M&A News Lighting Up TLRY, CGC, ACB and SNDL Today

Canadian Pot Stocks For Active Traders In 2022 The post Top Canadian Marijuana Stocks To Watch Before April appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Watch Before April

Cannabis Industry Updates and Current Events 2022 The post Cannabis Industry Trends To Watch For In 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Cannabis Industry Trends To Watch For In 2022

Agrify

Akanda Corp

Flora Growth Corp

Innovative Industrial Properties

IM Cannabis Corp

Chicago Atlantic Real Estate Finance

Urban-gro

The Valens Co

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.

10 Smoking Hot Cannabis Stocks to Keep on Your Radar

LEAMINGTON, Ontario, March 17, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has expanded its medical cannabis offering and launched the first EU GMP medical cannabis oil products in Malta. Tilray's EU-GMP medical cannabis products are now available in pharmacies across Malta, providing patients with safe and reliable access to high-quality medical cannabis.

Tilray Medical Expands Offering in Malta and Launches First Medical Cannabis Oil Products in Market

TLRY stock has tumbled 80% over the past year, but now expectations for Tilray are even higher after a milestone of net income in Q2 FY22. The post Tilray Stock Isn't a Buy Until It Proves Its Profitability Is Sustainable appeared first on InvestorPlace.

Tilray Stock Isn't a Buy Until It Proves Its Profitability Is Sustainable

Shareholders are now getting a two-companies-for-the-price-of-one deal with TLRY stock, but whether that's a good or not thing is debatable. The post If You're Going to Hold Tilray Stock, You'd Better Be a Fan of Hexo Too appeared first on InvestorPlace.

If You're Going to Hold Tilray Stock, You'd Better Be a Fan of Hexo Too

Greenlane Holdings

Incannex Healthcare Inc

Village Farms International

The 7 Hottest Cannabis Stocks To Watch This Week

The company's recent moves have me wondering just how safe this stock really is.

Is Tilray Making a Colossal Mistake?

If earnings growth is a catalyst for stock performance, then Tilray Brands Inc. (NASDAQ:TLRY) should be among the best performers. In the second quarter of 2022, the company swung into a net income of $6 million from a net loss of $89 million in the previous year.

Tilray is posting growing revenues but the stock is falling. Is it a risky buy?

A More Equitable Cannabis Industry

News for Tilray Brands Stock (TLRY)